Targeted Genetics to Host Conference Call and Webcast Discussion of First Quarter Results on August 6, 2008

SEATTLE, WA will report its second quarter 2008 financial results before the open of the financial markets on Wednesday, August 6, 2008. Following the announcement, management will host a conference call and webcast discussion of the financial results and provide a general corporate update beginning at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time. You may access the live webcast via the "Events" section found on the homepage of the Company's website at: www.targetedgenetics.com or via telephone at 800.240.4186 (domestic) or 303.275.2170 (international).

Replay Access

Webcast replay will be available for approximately 30 days at www.targetedgenetics.com; telephone replay will be available following Wednesday's call at approximately 9:30 a.m. PT through 11:59 p.m. PT, Saturday, September 6, 2008, by calling 800.405.2236 (domestic) or 303.590.3000 (international); pass code 11117734#.

About Targeted Genetics Corporation

Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, Leber's congenital amaurosis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at http://www.targetedgenetics.com.

Investor and Media Contact: Stacie D. Byars WeissComm Partners on behalf of Targeted Genetics Corporation 206.660.2588 Email Contact

Tecogen (NASDAQ:TGEN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024